glutamine has been researched along with sulfasalazine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baker, BJ; De Sarno, P; DeSilva, TM; Doyle, RE; Evonuk, KS; Gembitsky, I; Hewett, SJ; Johnston, BP; Moseley, CE; Raman, C; Sestero, CM; Tang, A; Weaver, CT | 1 |
| Jang, HJ; Kim, EH; Park, JY; Roh, JL; Shin, D | 1 |
| Aoki, D; Banno, K; Kawaguchi, S; Masuko, T; Minami, Y; Nagano, O; Nakayama, H; Okazaki, S; Otsuki, Y; Saya, H; Suina, K; Umene, K; Yamasaki, J; Yoshikawa, M | 1 |
| Gan, B; Koppula, P; Zhuang, L | 1 |
2 review(s) available for glutamine and sulfasalazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Cystine; DNA Methylation; Ferroptosis; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glutathione; Histones; Humans; Molecular Targeted Therapy; Neoplasms; Piperazines; Signal Transduction; Sorafenib; Sulfasalazine | 2021 |
4 other study(ies) available for glutamine and sulfasalazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Topics: Amino Acid Transport System y+; Animals; Animals, Newborn; Benzoates; Cell Movement; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Gene Expression; Glutamine; Glycine; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Microglia; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Oligodendroglia; Primary Cell Culture; Rats; Rats, Long-Evans; Sulfasalazine; Th1 Cells | 2015 |
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Topics: Amino Acid Transport System y+; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cisplatin; Cystine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Piperazines; Reactive Oxygen Species; RNA Interference; Sulfasalazine; Transfection; Xenograft Model Antitumor Assays | 2016 |
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Topics: Amino Acid Transport System ASC; Amino Acid Transport System y+; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cisplatin; Glutamate Dehydrogenase; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Ketoglutaric Acids; Metabolome; Mice; Mice, Nude; Minor Histocompatibility Antigens; Mitochondria; Molecular Targeted Therapy; Neoplastic Stem Cells; Oxidation-Reduction; Oxidative Stress; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Sulfasalazine | 2019 |